Cell Genesys (CEGE) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Genesys (CEGE)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: mts362 who wrote (849)	4/4/2000 11:02:00 AM
From: AurumRabosa	of 1298

The risk-free rate is higher than 5%. For 91-day Treasurys it's now 5.873% and for 182-day it's 6.166% which would yield $15.4 million per year and that's higher than their present burn rate. However, they are not restricted to investing the cash in risk-free investments. They can buy stocks, converts or notes in companies in their own field. They could earn 12% on junk bonds, for example. I feel comfortable in knowing that they have plenty of cash to focus on their business of developing new drugs and don't have to waste time fund raising. Buying late stage candidates sounds like a good use for the cash. I'll continue to average into a bigger position on dips. publicdebt.treas.gov

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next